Chun-Wang Yuan
Overview
Explore the profile of Chun-Wang Yuan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
110
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Jin Z, Zhou J, Chen J, Ding R, Scheiner B, Wang S, et al.
J Cachexia Sarcopenia Muscle
. 2024 Nov;
15(6):2705-2716.
PMID: 39604073
Background: Cancer cachexia can impact prognosis, cause resistance to anticancer treatments and affect the tolerability of treatments. This study aims to identify hepatocellular carcinoma (HCC) with cachexia by characterizing longitudinal...
2.
Jin Z, Chen J, Zhu X, Duan X, Xin Y, Zhong B, et al.
EClinicalMedicine
. 2024 May;
72:102622.
PMID: 38745965
Background: The role of transarterial chemoembolization (TACE) in the treatment of advanced hepatocellular carcinoma (HCC) is unconfirmed. This study aimed to assess the efficacy and safety of immune checkpoint inhibitors...
3.
Zhu H, Li H, Huang M, Yang W, Yin G, Zhong B, et al.
Signal Transduct Target Ther
. 2023 Feb;
8(1):58.
PMID: 36750721
There is considerable potential for integrating transarterial chemoembolization (TACE), programmed death-(ligand)1 (PD-[L]1) inhibitors, and molecular targeted treatments (MTT) in hepatocellular carcinoma (HCC). It is necessary to investigate the therapeutic efficacy...
4.
Li Z, Ren A, Yang D, Xu H, Wei J, Yuan C, et al.
BMC Med Imaging
. 2022 Oct;
22(1):176.
PMID: 36207686
Background: We aimed to evaluate the value of using preoperative magnetic resonance imaging (MRI) features and clinical indicators to predict the early response of hepatocellular carcinoma (HCC) to transcatheter arterial...
5.
Ma F, Yuan C, Liu J, Cao J, Wu D
ACS Appl Mater Interfaces
. 2019 May;
11(22):19902-19912.
PMID: 31074952
A colorimetric immunoassay is a powerful tool for detecting tumor markers, with outstanding advantages of visualization and convenience. This study designed a colorimetric immunoassay using the antibody/antigen to control the...
6.
Yuan C, Wang Z, Liu K, Liu D
Hepatobiliary Pancreat Dis Int
. 2018 Sep;
17(5):416-422.
PMID: 30262419
Background: Cancer stem cells (CSCs) accelerate the growth of hepatocellular carcinoma (HCC) residual after incomplete radiofrequency ablation (In-RFA). The present study aimed to detect the effects of In-RFA on stemness...
7.
Zhao D, Zhang T, Ma D, Wang W, Yuan C, Duan Y
Chin Med J (Engl)
. 2005 Jun;
118(12):1054-6.
PMID: 15978219
No abstract available.